Concept↦Documents↦Required Documents↦Protocol and Synopsis
Was betrifft es? Warum ist das wichtig?
The study protocol is the core document that:
- Describes the study background, objective(s) / hypothesis, outcome(s) / endpoint(s), study design, statistical method(s), including applicable safety aspects
- Lays down the rules for study conduct, that must be complies with by study staff and study participants
The protocol synopsis is a short summary of the protocol and provides a kind of roadmap or panoramic view of the planned study.
The protocol is often an extensive document. As a result, the synopsis is often presented when applying for grants or seeking other types of support.
Swissethics provides a selection of mandatory protocol templates. Which template to use depends on study:
- Type, such as ClinO, ClinO-MD studies, or Other Clinical Studies and HRO studies
- Risk-Category (i.e. with A low-, B intermediate-, and C high-risk studies)
Was muss ich befolgen?
As a SP-INV:
- Start by selecting the applicable protocol template provided by swissethics. The template ensures compliance with thel formal protocol structure, and provides comprehensive guidance on required protocol content
- Consider what additional support or expertise must be recruited for the protocol write-up (e.g. a study statistician, quality-, project-, data manager, an experienced study nurse)
Aspects to consider when writing your synopsis and study protocol, include to:
- Define the research question(s) / hypothesis of your study
- Decide on achievable and measurable study outcome(s) / endpoint(s)
- Define the statistical analysis plan. The plan includes the sample size calculation that defines the required number of participants needed to answer your research question(s)
- Choose a fit for purpose study design, while avoiding unnecessary complexity
- Define how study participant rights and safety can be protected
- Define how data quality can be guaranteed
Wo kann ich Hilfe anfordern?
Your local Research Support Centre↧ can assist you with experienced staff regarding this topic
Basel, Departement Klinische Forschung (DKF), dkf.unibas.ch
Lugano, Clinical Trials Unit (CTU-EOC), ctueoc.ch
Bern, Department of Clinical Research (DCR), dcr.unibe.ch
Geneva, Clinical Research Center (CRC), crc.hug.ch
Lausanne, Clinical Research Center (CRC), chuv.ch
St. Gallen, Clinical Trials Unit (CTU), h-och.ch
Zürich, Clinical Trials Center (CTC), usz.ch
External Links
Swissethics – see in particular
- Broad selection of protocol templates
References
ICH GCP E6(R3) – see in particular
- 1.44 Glossary: Protocol definition
- Appendix B. Clinical trial protocol and protocol amendment(s)
ICH GCP E8(R1) – see in particular guidelines:
- 2.2 Scientific approach to study planning and implementation
ISO 14155:2020 Medical devices - see in particular sections (access liable to cost)
- 6.4 Clinical Investigational Plan (CIP)
- Annex A CIP
Declaration of Helsinki – see in particular principles
- 21 – 22 Protocol requirements
Swiss Law
ClinO – see in particular articles
- Art. 19, 20, 49 and 61 Categorisation
ClinO-MD - see in particular
- Art. 6 Categorisation of clinical trials
HRO – see in particular articles
- Art. 7 Categorisation